300149 Stock Overview
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
ChemPartner PharmaTech Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.02 |
52 Week High | CN¥9.74 |
52 Week Low | CN¥3.68 |
Beta | 0.62 |
11 Month Change | 24.26% |
3 Month Change | -5.28% |
1 Year Change | -42.30% |
33 Year Change | -68.13% |
5 Year Change | -62.62% |
Change since IPO | -25.43% |
Recent News & Updates
Shareholder Returns
300149 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 29.4% | 3.9% | 0.8% |
1Y | -42.3% | -23.8% | -21.0% |
Return vs Industry: 300149 underperformed the CN Biotechs industry which returned -23.8% over the past year.
Return vs Market: 300149 underperformed the CN Market which returned -21% over the past year.
Price Volatility
300149 volatility | |
---|---|
300149 Average Weekly Movement | 8.5% |
Biotechs Industry Average Movement | 5.9% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 300149 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300149's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 1,916 | Swee Lian Woo | www.cppt.com.cn |
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.
ChemPartner PharmaTech Co.,Ltd. Fundamentals Summary
300149 fundamental statistics | |
---|---|
Market cap | CN¥2.50b |
Earnings (TTM) | -CN¥904.84m |
Revenue (TTM) | CN¥1.10b |
2.3x
P/S Ratio-2.8x
P/E RatioIs 300149 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300149 income statement (TTM) | |
---|---|
Revenue | CN¥1.10b |
Cost of Revenue | CN¥870.02m |
Gross Profit | CN¥234.28m |
Other Expenses | CN¥1.14b |
Earnings | -CN¥904.84m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | -1.82 |
Gross Margin | 21.22% |
Net Profit Margin | -81.94% |
Debt/Equity Ratio | 12.4% |
How did 300149 perform over the long term?
See historical performance and comparison